Arvind Mer
Cited by
Cited by
Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy
SK Rehman, J Haynes, E Collignon, KR Brown, Y Wang, AML Nixon, ...
Cell 184 (1), 226-242. e21, 2021
Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer
R Shi, N Radulovich, C Ng, N Liu, H Notsuda, M Cabanero, ...
Clinical Cancer Research 26 (5), 1162-1174, 2020
Proteogenomic characterization of pancreatic ductal adenocarcinoma
L Cao, C Huang, DC Zhou, Y Hu, TM Lih, SR Savage, K Krug, DJ Clark, ...
Cell 184 (19), 5031-5052. e26, 2021
Software for the Integration of Multiomics Experiments in Bioconductor
M Ramos, L Schiffer, A Re, R Azhar, A Basunia, C Rodriguez, T Chan, ...
Cancer research 77 (21), e39-e42, 2017
Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer
KL Thu, J Silvester, MJ Elliott, W Ba-Alawi, MH Duncan, AC Elia, AS Mer, ...
Proceedings of the National Academy of Sciences 115 (7), E1570-E1577, 2018
Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling
M Wang, J Lindberg, D Klevebring, C Nilsson, AS Mer, M Rantalainen, ...
Leukemia 31 (10), 2029-2036, 2017
Expression levels of long non-coding RNAs are prognostic for AML outcome
AS Mer, J Lindberg, C Nilsson, D Klevebring, M Wang, H Grönberg, ...
Journal of hematology & oncology 11 (1), 1-13, 2018
Integrative pharmacogenomics analysis of patient-derived xenografts
AS Mer, W Ba-Alawi, P Smirnov, YX Wang, B Brew, J Ortmann, MS Tsao, ...
Cancer research 79 (17), 4539-4550, 2019
Biological and therapeutic implications of a unique subtype of NPM1 mutated AML
AS Mer, EM Heath, SA Madani Tonekaboni, N Dogan-Artun, SK Nair, ...
Nature communications 12 (1), 1-13, 2021
CellWhere: graphical display of interaction networks organized on subcellular localizations
L Zhu, A Malatras, M Thorley, I Aghoghogbe, A Mer, S Duguez, ...
Nucleic acids research 43 (W1), W571-W575, 2015
MicroRNAs modulate the dynamics of the NF-κB signaling pathway
C Vaz, AS Mer, A Bhattacharya, R Ramaswamy
PLoS One 6 (11), e27774, 2011
Drug sensitivity prediction from cell line-based pharmacogenomics data: guidelines for developing machine learning models
H Sharifi-Noghabi, S Jahangiri-Tazehkand, P Smirnov, C Hon, ...
Briefings in Bioinformatics 22 (6), bbab294, 2021
A novel approach for protein subcellular location prediction using amino acid exposure
AS Mer, MA Andrade-Navarro
BMC bioinformatics 14 (1), 1-13, 2013
Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer
CA Chang, J Jen, S Jiang, A Sayad, AS Mer, KR Brown, AML Nixon, ...
Cancer discovery, 2021
Orchestrating and sharing large multimodal data for transparent and reproducible research
A Mammoliti, P Smirnov, M Nakano, Z Safikhani, C Eeles, H Seo, SK Nair, ...
Nature Communications 12 (1), 1-10, 2021
Integrative cancer pharmacogenomics to establish drug mechanism of action: drug repurposing
N El-Hachem, W Ba-alawi, I Smith, AS Mer, B Haibe-Kains
Pharmacogenomics 18 (16), 1469-1472, 2017
mBISON: Finding miRNA target over-representation in gene lists from ChIP-sequencing data
ML Gebhardt, AS Mer, MA Andrade-Navarro
BMC research notes 8 (1), 1-3, 2015
IPO11 regulates the nuclear import of BZW1/2 and is necessary for AML cells and stem cells
B Nachmias, DH Khan, V Voisin, AS Mer, GE Thomas, N Segev, ...
Leukemia 36 (5), 1283-1295, 2022
PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis
N Feizi, SK Nair, P Smirnov, G Beri, C Eeles, PN Esfahani, M Nakano, ...
Nucleic acids research 50 (D1), D1348-D1357, 2022
KuLGaP: A Selective Measure for Assessing Therapy Response in Patient-Derived Xenografts
J Ortmann, L Rampášek, E Tai, AS Mer, R Shi, EL Stewart, C Mascaux, ...
bioRxiv, 2020
The system can't perform the operation now. Try again later.
Articles 1–20